Wazir, Nauman, and Shafqat Ur Rehman. 2022. “Efficacy and Safety of Empagliflozin As Add-On Therapy in Patients of Type-2 Diabetes Mellitus”. Journal of Gandhara Medical and Dental Science 9 (1):24-27. https://doi.org/10.37762/jgmds.9-1.173.